Patents by Inventor Darin FALK

Darin FALK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF PERMITTING A SUBJECT TO RECEIVE MULTIPLE DOSES OF RECOMBINANT ADENO-ASSOCIATED VIRUS
    Publication number: 20220347297
    Abstract: Provided herein are compositions, kits and methods related to permitting a human or non-human primate subject to receive multiple doses of recombinant adeno-associate virus (rAAV) vectors. In some aspects, provided herein are methods comprising administering an anti-CD20 antibody, optionally in combination with an mTOR inhibitor, to the subject to permit multiple doses of an rAAV vector to be administered.
    Type: Application
    Filed: March 4, 2022
    Publication date: November 3, 2022
    Applicant: University of Florida Research Foundation, Incorporated
    Inventors: Barry John Byrne, Darin Falk, Manuela Corti
  • COMPOSITIONS AND METHODS FOR TREATMENT OF FRIEDREICHS ATAXIA
    Publication number: 20220211737
    Abstract: The present application provides compositions for treatment of Friedreich's Ataxia (FA). These include, but are not limited to, nucleic acid constructs and recombinant vectors comprising a human frataxin 5? untranslated region (5?UTR FXN) and a human frataxin (FXN) nucleotide sequence are provided herein. Also provided are methods for treatment of FA.
    Type: Application
    Filed: September 11, 2020
    Publication date: July 7, 2022
    Applicant: LACERTA THERAPEUTICS, INC.
    Inventors: Darin FALK, Edgardo RODRIGUEZ, Madhurima SAHA